← Back to headlines
Avalyn Surges on Public Debut
Lung disease drug developer Avalyn Pharmaceuticals saw its stock surge following its public debut, indicating strong investor interest.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
11 areas to reach ‘danger’ level heat indices on Labor Day
just now
FCT Police Commissioner orders mental health screening for personnel
just now
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
Novocure Provides 2026 Revenue Guidance and Optune Pax Launch Update
15m ago